1. From TNO-Quality of Life, Department of Biomedical Research, (S.M.P., M.G., C.C.H., H.M.G.P., P.C.N.R.) Gaubius Laboratory, Leiden, The Netherlands; Département d’Athérosclérose and INSERM U545 (C.F., G.L., B.S.), Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France; Leiden University Medical Center (C.C.H., P.C.N.R.), Department of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden, The Netherlands; and Leiden/Amsterdam Center for Drug...